search
Back to results

Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol

Primary Purpose

Critical Illness, Mechanical Ventilation

Status
Completed
Phase
Phase 2
Locations
Canada
Study Type
Interventional
Intervention
Sedation management strategy
Sponsored by
Mount Sinai Hospital, Canada
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for Critical Illness focused on measuring ICU, Sedation strategies, Daily sedative interruption, Sedation protocols

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: age>18 years Mechanically ventilated, with anticipated need for MV ≥ 48 hours ICU team has decided to initiate continuous sedative/analgesic infusion(s) informed consent. Exclusion Criteria: Admission after resuscitation from cardiac arrest Traumatic brain injury Currently receiving neuromuscular blocking agents Allergy to any of the study medications History of alcohol, sedative or analgesic abuse History of psychiatric illness Acute or chronic neurologic dysfunction Administration of sedatives for >24 hr, Lack of commitment to aggressive treatment Current enrollment in a related trial Previous enrollment in this trial.

Sites / Locations

  • Mount Sinai Hospital

Outcomes

Primary Outcome Measures

Duration of Mechanical Ventilation
ICU and Hospital Lengths of stay

Secondary Outcome Measures

Adverse events
Patient Recall
Caregiver workload

Full Information

First Posted
February 28, 2006
Last Updated
February 28, 2006
Sponsor
Mount Sinai Hospital, Canada
Collaborators
The Physicians' Services Incorporated Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00298493
Brief Title
Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol
Official Title
A Randomized Trial of Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol - A Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
February 2006
Overall Recruitment Status
Completed
Study Start Date
February 2001 (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
September 2004 (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
Mount Sinai Hospital, Canada
Collaborators
The Physicians' Services Incorporated Foundation

4. Oversight

5. Study Description

Brief Summary
All critically ill, mechanically ventilated patients in the Intensive Care Unit receive medications to relieve pain and anxiety. However, accumulation of these medications can be associated with serious complications, most notably longer time on the breathing machine and in the ICU. Two strategies have been shown to dramatically improve patient outcomes: nurse-directed protocols for giving sedation, and daily interruption of sedation. However, these strategies have not been widely adopted, because of physicians' concerns, and because it is unclear which strategy is better. Given that patient outcome is improved with either of these strategies, the fundamental question that arises is whether patients managed with a combination of two strategies which both reduce drug accumulation (protocolized sedation and daily interruption) have an even better outcome than patients managed with only one of them (protocolized sedation). We propose a multicenter study in which 700 critically ill, mechanically ventilated patients will have their sedation managed with protocolized sedation alone, or both strategies. Both groups of patients will have the following recorded: ICU and hospital lengths of stay, mortality, total sedative drug use, ICU human resources used, side effects and recall of their ICU stay. The results of this large multi-center trial will help to inform best practice with regard to sedation management of critically ill patients in Canada and elsewhere. In addition, reducing ICU stay could be economically attractive, as the cost of an ICU day in Canada is approximately $3000.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Critical Illness, Mechanical Ventilation
Keywords
ICU, Sedation strategies, Daily sedative interruption, Sedation protocols

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
65 (false)

8. Arms, Groups, and Interventions

Intervention Type
Procedure
Intervention Name(s)
Sedation management strategy
Primary Outcome Measure Information:
Title
Duration of Mechanical Ventilation
Title
ICU and Hospital Lengths of stay
Secondary Outcome Measure Information:
Title
Adverse events
Title
Patient Recall
Title
Caregiver workload

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: age>18 years Mechanically ventilated, with anticipated need for MV ≥ 48 hours ICU team has decided to initiate continuous sedative/analgesic infusion(s) informed consent. Exclusion Criteria: Admission after resuscitation from cardiac arrest Traumatic brain injury Currently receiving neuromuscular blocking agents Allergy to any of the study medications History of alcohol, sedative or analgesic abuse History of psychiatric illness Acute or chronic neurologic dysfunction Administration of sedatives for >24 hr, Lack of commitment to aggressive treatment Current enrollment in a related trial Previous enrollment in this trial.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Sangeeta Mehta, MD
Organizational Affiliation
MOUNT SINAI HOSPITAL
Official's Role
Principal Investigator
Facility Information:
Facility Name
Mount Sinai Hospital
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M5G 1X5
Country
Canada

12. IPD Sharing Statement

Citations:
PubMed Identifier
18552687
Citation
Mehta S, Burry L, Martinez-Motta JC, Stewart TE, Hallett D, McDonald E, Clarke F, Macdonald R, Granton J, Matte A, Wong C, Suri A, Cook DJ; Canadian Critical Care Trials Group. A randomized trial of daily awakening in critically ill patients managed with a sedation protocol: a pilot trial. Crit Care Med. 2008 Jul;36(7):2092-9. doi: 10.1097/CCM.0b013e31817bff85.
Results Reference
derived

Learn more about this trial

Daily Sedative Interruption in Critically Ill Patients Being Managed With a Sedation Protocol

We'll reach out to this number within 24 hrs